Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

DYNEX

Designs and manufactures fully-automated ELISA microplate workstations, laboratory instruments and associated consuma... read more Featured Products: More products

Download Mobile App




Automated ELISA System Delivers Speed, Precision and Flexibility to Clinical Diagnostic Labs

By LabMedica International staff writers
Posted on 02 Jan 2024

A new fully automated ELISA system featuring the latest enhancements helps achieve powerful lab proficiency while ensuring the security of data to meet all the requirements of 21 CFR Part 11.

DYNEX Technologies (Chantilly, VA, USA) has unveiled the Agility Integra fully automated ELISA system that brings speed, precision, and flexibility to clinical diagnostic laboratories. This high-throughput system comes with upgraded software capabilities for powerful results that comply with FDA Regulation 21 CFR Part 11. Agility Integra’s open system takes ELISA testing to the next level, by allowing multiple immunoassays to run simultaneously. It guarantees data integrity and security with improved audit trails, chain of custody, lab information system connectivity, and secure networking.

With Agility Integra, labs can benefit from high-volume, walk-away processing of multiple assays, faster automation and continuous loading of samples, fewer manual processes and improved workflows, and increased lab efficiency and maximum output, among others. Other advantages include enhanced import and export functionality, upgraded data encryption, and optimized reporting. This latest innovation represents the next step in DYNEX’s flagship automated microplate processor and offers unique value for highly regulated laboratory environments.

DYNEX Vice President of Innovation, Rich Bahlmann, views the Agility Integra system as “a true game changer in the realm of clinical research and drug development, offering superior pipetting accuracy and state-of-the-art data protection.” Mr. Bahlmann is confident that the system “will propel clinical research and drug development initiatives forward, paving the way for groundbreaking advancements within the pharmaceutical and biotechnology field.”

Related Links:
DYNEX Technologies

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.